Antonio Marchetti

10.4k total citations · 3 hit papers
111 papers, 5.8k citations indexed

About

Antonio Marchetti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Antonio Marchetti has authored 111 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 49 papers in Pulmonary and Respiratory Medicine and 36 papers in Cancer Research. Recurrent topics in Antonio Marchetti's work include Lung Cancer Treatments and Mutations (43 papers), Cancer Genomics and Diagnostics (31 papers) and Colorectal Cancer Treatments and Studies (18 papers). Antonio Marchetti is often cited by papers focused on Lung Cancer Treatments and Mutations (43 papers), Cancer Genomics and Diagnostics (31 papers) and Colorectal Cancer Treatments and Studies (18 papers). Antonio Marchetti collaborates with scholars based in Italy, United States and United Kingdom. Antonio Marchetti's co-authors include Fiamma Buttitta, Lara Felicioni, Antonio Chella, Sara Malatesta, Felice Mucilli, Fabio Barassi, Simona Salvatore, Rocco Sacco, Andrea Mezzetti and Carla Martella and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Antonio Marchetti

111 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment

2005 670 citations Antonio Marchetti, Carla Martella et al. profile →
Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients

2009 455 citations Federico Cappuzzo, Antonio Marchetti et al. profile →
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring BRAF Mutations

2011 422 citations Antonio Marchetti, Lara Felicioni et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonio Marchetti Italy	36	2.9k	2.7k	2.5k	2.0k	624	111	5.8k
Fiamma Buttitta Italy	45	2.9k 1.0×	3.5k 1.3×	3.6k 1.4×	2.4k 1.2×	702 1.1×	102	7.1k
Hélène Blons France	47	2.4k 0.8×	3.3k 1.2×	2.3k 0.9×	2.2k 1.1×	1.2k 2.0×	165	6.0k
Junichi Soh Japan	40	3.2k 1.1×	2.5k 0.9×	2.5k 1.0×	1.5k 0.8×	410 0.7×	211	5.5k
Gaia Schiavon United Kingdom	28	1.7k 0.6×	2.5k 0.9×	1.5k 0.6×	1.9k 1.0×	644 1.0×	105	4.6k
Hyo Sup Shim South Korea	37	3.1k 1.1×	2.4k 0.9×	1.5k 0.6×	1.1k 0.6×	410 0.7×	164	5.1k
Paul K. Paik United States	31	3.5k 1.2×	3.0k 1.1×	2.2k 0.8×	1.1k 0.6×	561 0.9×	155	5.6k
Antonio Chella Italy	39	3.5k 1.2×	2.9k 1.1×	1.6k 0.6×	1.2k 0.6×	340 0.5×	130	5.5k
Manuel R. Teixeira Portugal	43	1.9k 0.7×	1.7k 0.6×	3.4k 1.3×	1.9k 1.0×	1.3k 2.2×	225	6.4k
Umberto Malapelle Italy	43	2.8k 1.0×	2.6k 0.9×	2.1k 0.8×	2.4k 1.2×	836 1.3×	265	5.7k
Fernando López‐Ríos Spain	44	2.7k 0.9×	3.2k 1.2×	2.1k 0.8×	1.8k 0.9×	876 1.4×	177	6.4k

Countries citing papers authored by Antonio Marchetti

Since Specialization

Citations

This map shows the geographic impact of Antonio Marchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Marchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Marchetti more than expected).

Fields of papers citing papers by Antonio Marchetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Marchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Marchetti. The network helps show where Antonio Marchetti may publish in the future.

Co-authorship network of co-authors of Antonio Marchetti

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Marchetti. A scholar is included among the top collaborators of Antonio Marchetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Marchetti. Antonio Marchetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lazzaro, Carlo, Giovanni Fattore, Massimo Barberis, et al.. (2023). Full cost of diagnostic pathology for lung carcinoma in Italy: results from four Pathology Units. Pathologica. 115(2). 83–89. 2 indexed citations

Subramanian, Janakiraman, Natasha B. Leighl, Yoon‐La Choi, et al.. (2022). Usage of epidermal growth factor mutation testing and impact on treatment patterns in non-small cell lung cancer: An international observational study. Lung Cancer. 175. 47–56. 1 indexed citations

Fumagalli, Caterina, Elena Guerini‐Rocco, Fiamma Buttitta, et al.. (2020). Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS Network. Journal of Clinical Pathology. 74(10). 668–672. 3 indexed citations

Keppens, Cleo, Elisabeth Dequeker, Étienne Rouleau, et al.. (2020). Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples. BMC Cancer. 20(1). 366–366. 3 indexed citations

Cheung, Carol C., Corrado D’Arrigo, Manfred Dietel, et al.. (2016). Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers. Applied immunohistochemistry & molecular morphology. 25(1). 4–11. 30 indexed citations

Cappuzzo, Federico, Giovanna Finocchiaro, Francesco Grossi, et al.. (2014). Phase II Study of Afatinib, an Irreversible ErbB Family Blocker, in EGFR FISH-Positive Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 10(4). 665–672. 22 indexed citations

Marchetti, Antonio, Massimo Barberis, Mauro Papotti, et al.. (2014). ALK Rearrangement Testing by FISH Analysis in Non–Small-Cell Lung Cancer Patients: Results of the First Italian External Quality Assurance Scheme. Journal of Thoracic Oncology. 9(10). 1470–1476. 16 indexed citations

Pasquale, Giuseppe Di, Antonio Marchetti, Irene Capelli, et al.. (2014). Relationship between coronary artery disease and C-reactive protein levels in NSTEMI patients with renal dysfunction: a retrospective study. BMC Nephrology. 15(1). 152–152. 13 indexed citations

Marchetti, Antonio, Andrea Ardizzoni, Mauro Papotti, et al.. (2013). Recommendations for the Analysis of ALK Gene Rearrangements in Non–Small-Cell Lung Cancer: A Consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and Cytopathology. Journal of Thoracic Oncology. 8(3). 352–358. 40 indexed citations

10.

Cappuzzo, Federico, Yong Gon Cho, Andrea Sacconi, et al.. (2012). p95HER2 Truncated Form in Resected Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 7(3). 520–527. 15 indexed citations

11.

Pirker, Robert, Felix Herth, Keith M. Kerr, et al.. (2010). Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop. Journal of Thoracic Oncology. 5(10). 1706–1713. 228 indexed citations

12.

Marchetti, Antonio, Michèle Milella, Lara Felicioni, et al.. (2009). Clinical Implications of KRAS Mutations in Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors: An Important Role for Mutations in Minor Clones. Neoplasia. 11(10). 1084–1092. 84 indexed citations

13.

Heras, M. De las, Pablo R. Murcia, Aurora Ortı́n, et al.. (2007). Jaagsiekte sheep retrovirus is not detected in human lung adenocarcinomas expressing antigens related to the Gag polyprotein of betaretroviruses. Cancer Letters. 258(1). 22–30. 11 indexed citations

14.

Buttitta, Fiamma, Lara Felicioni, Fabio Barassi, et al.. (2005). PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma. The Journal of Pathology. 208(3). 350–355. 86 indexed citations

15.

Marchetti, Antonio, Nicola Tinari, Fiamma Buttitta, et al.. (2002). Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients.. PubMed. 62(9). 2535–9. 103 indexed citations

16.

Marchetti, Antonio, Fiamma Buttitta, Gloria Bertacca, et al.. (2001). mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. The Journal of Pathology. 195(2). 186–190. 35 indexed citations

17.

Marchetti, Antonio, Fiamma Buttitta, Vittoria Carnicelli, et al.. (1997). Enriched SSCP. Diagnostic Molecular Pathology. 6(4). 185–191. 12 indexed citations

18.

Marchetti, Antonio, Fiamma Buttitta, Silvia Pellegrini, et al.. (1996). BRONCHIOLOALVEOLAR LUNG CARCINOMAS: K-ras MUTATIONS ARE CONSTANT EVENTS IN THE MUCINOUS SUBTYPE. The Journal of Pathology. 179(3). 254–259. 92 indexed citations

19.

Caforio, Alida L.P., Bruno Rossi, Gabriele Siciliano, et al.. (1989). Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: Evidence of subclinical myogenic myopathy. Journal of the American College of Cardiology. 14(6). 1464–1473. 49 indexed citations

20.

Rossi, Bruno, et al.. (1986). Toxic myopathy induced by industrial minerals oils: Clinical and histopathological features. Neurological Sciences. 7(6). 599–604. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact